Synthetic phosphopeptides to treat bone diseases

This invention relates to phosphopeptides SIGNIFICANT DECLINE IN A WAY THE BONE LOSS OR embrittlement and a process allowing the treatment or prevention of conditions associated with embrittlement BONE LOSS OR MANAGING SUCH phosphopeptides orally or parenterally. After 35 years, bone mass, mineral content MECHANICAL STRENGTH AND BONE GRADUALLY BEGIN TO DECREASE. FIGURE shows the relationship between bone mass and age.